is bpc 157 intramuscular or subcutaneous bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA bpc-157 injection subcutaneous vs intramuscular
Description
Adequate Vitamin B12 levels contribute to better overall health, reduced risk of anemia, improved nerve health, and enhanced energy levels
Vegetarians and Stroke Risk FactorsVitamin B12 and Homocysteine
The FDAs 2013 confirmation that the original product was not withdrawn for safety reasons provides additional confidence in the peptides tolerability profile
So for people that suffer from IBS, irritable bowel syndrome, or from colitis, or from other gut issues, There is a potential use for therapeutic peptides
